KLOTHO heterozygosity attenuates APOE4 -related amyloid burden in preclinical AD
Authors:
- Claire M. EricksonCEClaire M. Erickson
- Stephanie A. SchultzSSStephanie A. Schultz
- Jennifer M. OhJOJennifer M. Oh
- Burcu F. DarstBDBurcu F. Darst
- Yue MaYMYue Ma
- Derek NortonDNDerek Norton
- Tobey BetthauserTBTobey Betthauser
- Catherine L. GallagherCGCatherine L. Gallagher
- Cynthia M. CarlssonCCCynthia M. Carlsson
- Barbara B. BendlinBBBarbara B. Bendlin
- Sanjay AsthanaSASanjay Asthana
- Bruce P. HermannBHBruce P. Hermann
- 16 April 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 92 (16) , e1878-e1889
Abstract
Objective To examine whether the KLOTHO gene variant KL-VS attenuates APOE4-associated β-amyloid (Aβ) accumulation in a late-middle-aged cohort enriched with Alzheimer disease (AD) risk factors. Methods Three hundred nine late-middle-aged adults from the Wisconsin Registry for Alzheimer9s Prevention and the Wisconsin Alzheimer9s Disease Research Center were genotyped to determine KL-VS and APOE4 status and underwent CSF sampling (n = 238) and/or 11C-Pittsburgh compound B (PiB)-PET imaging (n = 183). Covariate-adjusted regression analyses were used to investigate whether APOE4 exerted expected effects on Aβ burden. Follow-up regression analyses stratified by KL-VS genotype (i.e., noncarrier vs heterozygous; there were no homozygous individuals) evaluated whether the influence of APOE4 on Aβ was different among KL-VS heterozygotes compared to noncarriers. Results APOE4 carriers exhibited greater Aβ burden than APOE4-negative participants. This effect was stronger in CSF (t = −5.12, p < 0.001) compared with PiB-PET (t = 3.93, p < 0.001). In the stratified analyses, this APOE4 effect on Aβ load was recapitulated among KL-VS noncarriers (CSF: t = −5.09, p < 0.001; PiB-PET: t = 3.77, p < 0 .001). In contrast, among KL-VS heterozygotes, APOE4-positive individuals did not exhibit higher Aβ burden than APOE4-negative individuals (CSF: t = −1.03, p = 0.308; PiB-PET: t = 0.92, p = 0.363). These differential APOE4 effects remained after KL-VS heterozygotes and noncarriers were matched on age and sex. Conclusion In a cohort of at-risk late-middle-aged adults, KL-VS heterozygosity was associated with an abatement of APOE4-associated Aβ aggregation, suggesting KL-VS heterozygosity confers protections against APOE4-linked pathways to disease onset in AD.Keywords
This publication has 50 references indexed in Scilit:
- Improved kinetic analysis of dynamic PET data with optimized HYPR‐LRMedical Physics, 2012
- Amyloid‐beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B dataAnnals of Neurology, 2011
- Inter-rater reliability of manual and automated region-of-interest delineation for PiB PETNeuroImage, 2011
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- APOE-4 Genotype and Neurophysiological Vulnerability to Alzheimer's and Cognitive AgingAnnual Review of Clinical Psychology, 2009
- APOE ε4 allele predicts faster cognitive decline in mild Alzheimer diseaseNeurology, 2008
- Suppression of Aging in Mice by the Hormone KlothoScience, 2005
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993